Research Notes: Prognosis and treatment of Tysabri-related Progressive Multifocal Leukoencephalopathy

This page collects vetted references on medical safety, regulatory guidance, and clinical background for anyone researching this topic.

Detailed topic guide

Prognosis and treatment of Tysabri-related Progressive Multifocal Leukoencephalopathy — Research Summary

In-depth context and analysis on this topic for researchers and advocates.

World Health Organization (WHO)

Reference: World Health Organization (WHO)

Authoritative source for clinical, regulatory, and public-health background reading.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.